BACKGROUND: We investigated the contractile response of human coronary microvasculature to thromboxane A-2 (TXA-2), with and without the blockade of TXA-2 receptors or the inhibition of phospholipase-C (PLC) or of protein kinase C-α (PKC-α) in the human coronary microvasculature before and after cardioplegia, followed by reperfusion (CP/Rep). Protein/gene expression and localization of TXA-2 receptors, TXA-2 synthase, PLC, and other TXA-2-related proteins was also examined. METHODS: Right atrial tissue was harvested before and after cold blood cardioplegia, followed by about 10 minutes of reperfusion, from 28 patients undergoing cardiac operations. Coronary arterioles (90 to 170 μm in diameter) were dissected from the harvested tissue. RESULTS: The post-CP/Rep contractile response of coronary arterioles to TXA-2 analog U-46619 was significantly impaired vs pre-CP/Rep (p<0.05). The TXA-2 receptor antagonist SQ-29548 (10(-6) M) prevented the contractile response to U-46619 (p<0.05). Pretreatment with the PLC inhibitor U73122 (10(-6) M) significantly inhibited the U-46619-induced contractile response (p<0.05). Administration of the PKC-α inhibitor safingol failed to affect U-46619-induced contraction. Total protein levels and gene expression of TXA-2 receptors, TXA-2 synthase, PLC-β3, phospho-PLC-β3, PLC-γ1, and phospho-PLC-γ1 were not altered after CP/Rep. Confocal microscopy showed no significant differences in the expression of TXA-2 receptors or PLC-β3 in the microcirculation. TXA-2 receptors and PLC-β3 were both present in smooth muscle and endothelium. CONCLUSIONS: Cardioplegia/Rep decreases the contractile response of human coronary arterioles to TXA-2 soon after cardiac operations. The contractile response to the TXA-2 analog U-46619 is through activation of TXA-2 receptors and PLC.
BACKGROUND: We investigated the contractile response of human coronary microvasculature to thromboxane A-2 (TXA-2), with and without the blockade of TXA-2 receptors or the inhibition of phospholipase-C (PLC) or of protein kinase C-α (PKC-α) in the human coronary microvasculature before and after cardioplegia, followed by reperfusion (CP/Rep). Protein/gene expression and localization of TXA-2 receptors, TXA-2 synthase, PLC, and other TXA-2-related proteins was also examined. METHODS: Right atrial tissue was harvested before and after cold blood cardioplegia, followed by about 10 minutes of reperfusion, from 28 patients undergoing cardiac operations. Coronary arterioles (90 to 170 μm in diameter) were dissected from the harvested tissue. RESULTS: The post-CP/Rep contractile response of coronary arterioles to TXA-2 analog U-46619 was significantly impaired vs pre-CP/Rep (p<0.05). The TXA-2 receptor antagonist SQ-29548 (10(-6) M) prevented the contractile response to U-46619 (p<0.05). Pretreatment with the PLC inhibitor U73122 (10(-6) M) significantly inhibited the U-46619-induced contractile response (p<0.05). Administration of the PKC-α inhibitor safingol failed to affect U-46619-induced contraction. Total protein levels and gene expression of TXA-2 receptors, TXA-2 synthase, PLC-β3, phospho-PLC-β3, PLC-γ1, and phospho-PLC-γ1 were not altered after CP/Rep. Confocal microscopy showed no significant differences in the expression of TXA-2 receptors or PLC-β3 in the microcirculation. TXA-2 receptors and PLC-β3 were both present in smooth muscle and endothelium. CONCLUSIONS: Cardioplegia/Rep decreases the contractile response of human coronary arterioles to TXA-2 soon after cardiac operations. The contractile response to the TXA-2 analog U-46619 is through activation of TXA-2 receptors and PLC.
Authors: Marc Ruel; Tanveer A Khan; Pierre Voisine; Cesario Bianchi; Frank W Sellke Journal: Eur J Cardiothorac Surg Date: 2004-11 Impact factor: 4.191
Authors: Jun Feng; Louis M Chu; Michael P Robich; Richard T Clements; Kamal R Khabbaz; Robert Hagberg; Yuhong Liu; Robert M Osipov; Frank W Sellke Journal: Circulation Date: 2010-09-14 Impact factor: 29.690
Authors: J E Bleasdale; N R Thakur; R S Gremban; G L Bundy; F A Fitzpatrick; R J Smith; S Bunting Journal: J Pharmacol Exp Ther Date: 1990-11 Impact factor: 4.030
Authors: J G Byrne; R F Appleyard; S C Sun; G S Couper; J A Sloane; R G Laurence; L H Cohn Journal: J Thorac Cardiovasc Surg Date: 1993-04 Impact factor: 5.209
Authors: Jun Feng; Yuhong Liu; Kamal R Khabbaz; Robert Hagberg; Neel R Sodha; Robert M Osipov; Frank W Sellke Journal: Surgery Date: 2010-01-15 Impact factor: 3.982
Authors: Jun Feng; Yuhong Liu; Ashraf A Sabe; Ahmed A Sadek; Arun K Singh; Neel R Sodha; Frank W Sellke Journal: Eur J Cardiothorac Surg Date: 2015-06-11 Impact factor: 4.191
Authors: Benjamin Mirman; Ian Ikeda; Zhiqi Zhang; Yuhong Liu; Lucy Yu; Afshin Ehsan; Jun Feng; Frank Sellke Journal: Surgery Date: 2020-05-31 Impact factor: 3.982
Authors: Nicholas Sellke; Alex Kuczmarski; Isabella Lawandy; Victoria L Cole; Afshin Ehsan; Arun K Singh; Yuhong Liu; Frank W Sellke; Jun Feng Journal: J Thorac Cardiovasc Surg Date: 2018-06-08 Impact factor: 5.209
Authors: Andrew A Rebel; Siri A Urquhart; Kendra L Puig; Atreyi Ghatak; Stephen A Brose; Mikhail Y Golovko; Colin K Combs Journal: J Neurosci Res Date: 2015-02-22 Impact factor: 4.164
Authors: Olivia Ziegler; Kelsey Anderson; Yuhong Liu; Afshin Ehsan; James Fingleton; Neel Sodha; Jun Feng; Frank W Sellke Journal: Surgery Date: 2019-09-04 Impact factor: 3.982